In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: Multicenter national study GEIH-REIPI-Ab 2010;Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010)

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 31, Issue 1, 2013, Pages 4-9

  Fernández Cuenca, Felipe ^a   Tomás Carmona, María ^b   Caballero Moyano, Francisco ^a   Bou, Germán ^b   Martínez Martínez, Luis ^c   Vila, Jordi ^d   Pachón, Jerónimo ^e   Cisneros, José Miguel ^e   Rodríguez Baño, Jesús ^a   Pascual, Álvaro ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d UNIVERSITY OF SEVILLE   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acinetobacter baumannii; Antimicrobial susceptibility; Multicenter national study 2000 2010

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DOXYCYCLINE; GENTAMICIN; MINOCYCLINE; PIPERACILLIN; RIFAMPICIN; SULBACTAM; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; IN VITRO STUDY; NONHUMAN;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84872326592     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2012.06.010     Document Type: Article

References (30)

1. A.Y. Peleg, H. Seifert, and D.L. Paterson Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 2008 538 582
2. L.C. Antunes, F. Imperi, A. Carattoli, and P. Visca Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity PLoS One 6 2011 e22674
3. P. Visca, H. Seifert, and K.J. Towner Acinetobacter infection - an emerging threat to human health IUBMB Life 63 2011 1048 1054
4. P. Espinal, S. Martí, and J. Vila Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces J Hosp Infect 80 2012 56 60
5. F. Perez, A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather, and R.A. Bonomo Global challenge of multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 3471 3484
6. M. Kempf, and J.M. Rolain Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options Int J Antimicrob Agents 39 2012 105 114
7. J. Rodríguez-Baño, L. García, E. Ramírez, L. Martínez-Martínez, M.A. Muniain, and F. Fernández-Cuenca Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach Am J Infect Control 37 2009 715 722
8. R. Valencia, L.A. Arroyo, M. Conde, J.M. Aldana, M.J. Torres, and F. Fernández-Cuenca Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital Infect Control Hosp Epidemiol 30 2009 257 263
9. J. Vila, and J. Pachón Therapeutic options for Acinetobacter baumannii infections Expert Opin Pharmacother 9 2008 587 599
10. P.J. Turner MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates Diagn Microbiol Infect Dis 63 2009 217 222
11. P.R. Rhomberg, and R.N. Jones Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008) Diagn Microbiol Infect Dis 65 2009 414 426
12. A.C. Gales, R.N. Jones, and H.S. Sader Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09) J Antimicrob Chemother 66 2011 2070 2074
13. A.C. Rodloff, R. Leclercq, E.A. Debbia, R. Cantón, B.A. Oppenheim, and M.J. Dowzicky Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial Clin Microbiol Infect 14 2008 307 314
14. S. Miyakis, A. Pefanis, and A. Tsakris The challenges of antimicrobial drug resistance in Greece Clin Infect Dis 53 2011 177 184
15. Z. Chen, S. Qlu, Y. Wang, Y. Wang, S. Liu, and Z. Wang Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China Clin Infect Dis 52 2011 692 693
16. Y.S. Park, H. Lee, K.S. Lee, S.S. Hwang, Y.K. Cho, and H.Y. Kim Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases-a multicentre study Int J Antimicrob Agents 36 2010 430 435
17. F. Fernández-Cuenca, A. Pascual, A. Ribera, J. Vila, G. Bou, and J.M. Cisneros Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000) Enferm Infecc Microbiol Clin 22 2004 267 271
18. J.J. Picazo, C. Betriu, I. Rodríguez-Avial, E. Culebras, M. Gómez, and F. López Antimicrobial resistance surveillance: VIRA STUDY 2006 Enferm Infecc Microbiol Clin 24 2006 617 628
19. M. Guembe, E. Cercenado, L. Alcalá, M. Marín, R. Insa, and E. Bouza Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007 Rev Esp Quimioter 21 2008 166 173
20. C. Gimeno, R. Cantón, A. García, M. Gobernado Grupo Español de Estudio de Doripenem Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study Rev Esp Quimioter 23 2010 144 152
21. P. Villalón, S. Valdezate, M.J. Medina-Pascual, V. Rubio, A. Vindel, and J.A. Saez-Nieto Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain J Clin Microbiol 49 2011 875 882
22. M. Vaneechoutte, L. Dijkshoorn, I. Tjernberg, A. Elaichouni, P. de Vos, and G. Claeys Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis J Clin Microbiol 33 1995 11 15
23. Espinal P, Seifert H, Dijkshoorn L, Vila J, Roca I. Rapid and accurate identification of species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect. 2011 Oct 13. doi:10.1111/j.1469-0691.2011. 03696.x.
24. Clinical Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; 20th information supplement (June 2010 update). M100-S20 June 2010 Update 2010 Wayne, PA Clinical and Laboratory Standards Institute
25. Comité de l'Antibiogramme de la Société Française de Microbiologie. Recommandations 2010 [consultado 9 Feb 2012]. Paris, France: Société Française de Microbiologie. Disponible en: http://www.sfm-microbiologie.org
26. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID); 2009 [consultado 9 Feb 2012]. Disponible en: http://www.eucast.org
27. A.P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, and C.G. Giske Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 18 2012 268 281
28. K.S. Ko, J.Y. Suh, K.T. Kwon, S.I. Jung, K.H. Park, and C.I. Kang High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea J Antimicrob Chemother 60 2007 1163 1167
29. R.R. Reinert, D.E. Low, F. Rossi, X. Zhang, C. Wattal, and M.J. Dowzicky Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline J Antimicrob Chemother 60 2007 1018 1029
30. S. Navon-Venezia, A. Leavitt, and Y. Carmeli High tigecycline resistance in multidrug-resistant Acinetobacter baumannii J Antimicrob Chemother 59 2007 772 774